Midkine Antibody Summary
Immunogen |
Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human Midkine. The exact sequence is proprietary.
|
Localization |
Secreted
|
Predicted Species |
Porcine (100%). Backed by our 100% Guarantee.
|
Isotype |
IgG
|
Clonality |
Polyclonal
|
Host |
Rabbit
|
Gene |
MDK
|
Purity |
Immunogen affinity purified
|
Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
Dilutions |
|
Theoretical MW |
16 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
Packaging, Storage & Formulations
Storage |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
|
Buffer |
0.1M Tris (pH 7.0), 0.1M Glycine and 10% Glycerol
|
Preservative |
0.01% Thimerosal
|
Concentration |
0.33 mg/ml
|
Purity |
Immunogen affinity purified
|
Alternate Names for Midkine Antibody
- Amphiregulin-associated protein
- ARAP
- MDK
- MEK
- Midgestation and kidney protein
- midkine (neurite growth-promoting factor 2)
- Midkine
- MK1
- MKARAP
- NEGF2
- NEGF2FLJ27379
- Neurite outgrowth-promoting factor 2
- Neurite outgrowth-promoting protein
Background
Midkine (MK) is a 13 kDa heparin-binding polypeptide which enhances neurite outgrowth, neuronal cell survival and plasminogen activator activity. MK is structurally divided into two domains, and most of the biological activities are located on the C-terminal domain. Both domains consist of three antiparallel beta-strands, but the C-terminal domain has a long flexible hairpin loop where a heparin-binding consensus sequence is located (1). MK is a member of a highly conserved, developmentally regulated human gene family. The gene product exhibits neurite outgrowth-promoting activity and may play a role in nervous system development and/or maintenance. Expression of MK is predominant only for a short period from approximately one-half to two-thirds of the way through gestation; before and after that, it is barely detectable (2)